TABLE 1.
Designation | Position (length in aa) | Amino acid sequencea | MHC-I restriction |
---|---|---|---|
Controls | |||
Lymphocytic choriomeningitis virus | 118–126 (10) | RPQASGVYM | H-2Ld |
Influenza virus nucleoprotein | 366–374 (9) | ASNENMETM | H-2Db |
Peptidesb | |||
P1 | 97–108 (12) | AGTVNIGASDAY | H-2Db |
P2 | 142–150 (9) | HLKLNGKVL | H-2Db |
P3 | 166–175 (10) | IAALNPGVNL | H-2Db |
P4 | 309–318 (10) | YPIINYEYAI | H-2Db |
P5 | 340–349 (10) | ITDGNKASFL | H-2Db |
Lipopeptides | |||
LP1 | 97–108 (12) | PA-CSS AGTVNIGASDAY | H-2Db |
LP3 | 166–175 (10) | PA-CSS-IAALNPGVNL | H-2Db |
LP4 | 309–318 (10) | PA-CSS-YPIINYEYAI | H-2Db |
Predicted anchor residues are underlined. PA, palmitic acid.
Based on the amino acid sequence of the 38-kDa lipoglycoprotein published by Vordermeier et al. (34).